Cargando…

How cardiologists manage antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary stenting: the WOEST survey 2018

BACKGROUND: Antithrombotic treatment choices are complicated when patients have both atrial fibrillation (AF) and acute coronary syndrome and/or undergo percutaneous coronary intervention (PCI). In this study, we aimed to gain insight into antithrombotic management strategies in daily clinical pract...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Veer, A. J. W. M., Bennaghmouch, N., Dewilde, W. J. M., ten Berg, J. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bohn Stafleu van Loghum 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904986/ https://www.ncbi.nlm.nih.gov/pubmed/33052578 http://dx.doi.org/10.1007/s12471-020-01500-3

Ejemplares similares

The WOEST 2 registry: A prospective registry on antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention
por: de Veer, A. J. W. M., et al.
Publicado: (2022)

Changes in Antithrombotic Therapy Over Time and Durability of a Prasugrel WOEST-Like Regimen for Percutaneous Coronary Intervention Patients With Atrial Fibrillation　― Post Hoc Analysis of the PENDULUM Mono and PENDULUM Registries ―
por: Nakao, Koichi, et al.
Publicado: (2022)

Management and outcomes of real-world use of non-vitamin-K oral anticoagulants (NOACs) in patients with atrial fibrillation: experience of a dedicated NOAC clinic
por: de Veer, A. J. W. M., et al.
Publicado: (2019)

First report of a comparative patient-oriented perspective on the use of non-vitamin-K oral anticoagulants or vitamin-K antagonists in atrial fibrillation: patients’ experiences, side-effects and practical problems leading to non-adherence
por: Bennaghmouch, N., et al.
Publicado: (2019)

Correction to: First report of a comparative patient-oriented perspective on the use of non-vitamin-K oral anticoagulants or vitamin-K antagonists in atrial fibrillation: patients’ experiences, side-effects and practical problems leading to non-adherence
por: Bennaghmouch, N., et al.
Publicado: (2021)

Antithrombotic Strategy in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention
por: Kwak, Soongu, et al.
Publicado: (2019)

Antithrombotic treatment in atrial fibrillation patients needing percutaneous coronary intervention
por: Huisman, M. V.
Publicado: (2021)

Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation After Coronary Stent Implantation
por: Jang, Sung-Won, et al.
Publicado: (2011)

Experiences of Patients With Atrial Fibrillation With Combination Antithrombotic Therapy Post–Percutaneous Coronary Intervention
por: Poirier, Caylie M., et al.
Publicado: (2023)

Atrial fibrillation: trends in prevalence and antithrombotic prescriptions in the community
por: Joosten, L. P. T., et al.
Publicado: (2022)

Updated overview of evidence on optimal antithrombotic therapy in patients with atrial fibrillation undergoing percutanous coronary intervention
por: Koziński, Marek, et al.
Publicado: (2020)

Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
por: De Luca, Leonardo, et al.
Publicado: (2022)

Antithrombotic Therapy With Ticagrelor in Atrial Fibrillation Subjects After Percutaneous Coronary Intervention
por: Lu, Wenbin, et al.
Publicado: (2021)

Assessment of the Adherence of Cardiologists to Guidelines for the Treatment of Atrial Fibrillation
por: van der Sand, Cézar R., et al.
Publicado: (2013)

Optimal antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention: triple therapy is too much!
por: Jacobs, M. S., et al.
Publicado: (2018)

Effect of New Evidence on Antithrombotic Therapies in Atrial Fibrillation Patients Who Undergo Percutaneous Coronary Intervention in Alberta, Canada
por: Eberhardt, Theresa E., et al.
Publicado: (2021)

Comparative Safety and Efficacy of Eight Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
por: Liang, Bo, et al.
Publicado: (2022)

Atrial fibrillation and percutaneous coronary intervention: Are newer antithrombotic agents better for older patients?
por: Leggio, Massimo, et al.
Publicado: (2018)

Critical Appraisal of Guidelines for Antithrombotic Therapy in Atrial Fibrillation Post-Percutaneous Coronary Intervention
por: Fan, Yongqiang, et al.
Publicado: (2022)

Antithrombotic treatment and outcome after endovascular treatment and acute carotid artery stenting in stroke patients with atrial fibrillation
por: Weller, Johannes M., et al.
Publicado: (2022)

Time‐trends and treatment gaps in the antithrombotic management of patients with atrial fibrillation after percutaneous coronary intervention: Insights from the CHUM AF‐STENT Registry
por: Boivin‐Proulx, Laurie‐Anne, et al.
Publicado: (2019)

ANMCO position paper on antithrombotic treatment of patients with atrial fibrillation undergoing intracoronary stenting and/or acute coronary syndromes
por: De Luca, Leonardo, et al.
Publicado: (2022)

Evolution of and Evidence-Practice Gaps in Antithrombotic Management of Atrial Fibrillation Patients After Percutaneous Coronary Intervention
por: Boivin-Proulx, Laurie-Anne, et al.
Publicado: (2022)

Optimal long-term antithrombotic management of atrial fibrillation: life cycle management
por: Pisters, R., et al.
Publicado: (2018)

Antithrombotic management of patients with atrial fibrillation—Dutch anticoagulant initiatives anno 2020
por: Chu, G., et al.
Publicado: (2020)

Outcomes in relation to antithrombotic therapy among patients with atrial fibrillation after percutaneous coronary intervention
por: Park, Jiesuck, et al.
Publicado: (2020)

Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting: hovering among bleeding risk, thromboembolic events, and stent thrombosis
por: Menozzi, Mila, et al.
Publicado: (2012)

Choice of antithrombotic therapy for patients with atrial fibrillation undergoing carotid angioplasty and stenting: a nationwide population-based study
por: Huang, Yung-Chuan, et al.
Publicado: (2022)

Same rhythm, different song—approaches to atrial fibrillation management by cardiologists and nephrologists
por: Mark, Patrick B., et al.
Publicado: (2020)

Evolution of Antithrombotic Management of Atrial Fibrillation After Percutaneous Coronary Intervention Over 10 Years and Guidelines Uptake
por: Beaulieu, Marie-Claude, et al.
Publicado: (2021)

Antithrombotic Management for Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention or With Acute Coronary Syndrome: An Evidence-Based Update
por: Zhao, Shujuan, et al.
Publicado: (2021)

Temporal Trends in Antithrombotic Therapy for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention From 2014 to 2022 in Japan
por: Nakano, Yasuhiro, et al.
Publicado: (2023)

A Cardiologists’ Survey on the Use of Anticoagulants and Antiplatelets in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Those Undergoing Percutaneous Coronary Intervention in India
por: Kulkarni, Namrata, et al.
Publicado: (2023)

Antithrombotic management of patients with acute coronary syndrome and atrial fibrillation undergoing coronary stenting: a prospective, observational, nationwide study
por: De Luca, Leonardo, et al.
Publicado: (2020)

The use of antithrombotics in patients presenting with stroke and atrial fibrillation
por: Burgess, Carl, et al.
Publicado: (2007)

Update on Antithrombotic Therapy for Stroke Prevention in Atrial Fibrillation
por: Abcede, Hermelinda G., et al.
Publicado: (2010)

The sunset of triple antithrombotic therapy for atrial fibrillation patients
por: Capranzano, Piera
Publicado: (2019)

Comorbidities and Antithrombotic Treatment Pattern in Patients With Atrial Fibrillation
por: Bang, Oh Young, et al.
Publicado: (2022)

Current practice of Dutch cardiologists in detecting and diagnosing atrial fibrillation: results of an online case vignette study
por: Verbiest-van Gurp, N., et al.
Publicado: (2017)

The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE‐DUAL PCI subgroup analysis and comparison to other dual antithrombotic therapy trials)
por: Eccleston, David S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b6a9erg9c2ih2iq7oqb1g9o9ho